Each year, millions worldwide grapple with immune-mediated inflammatory diseases (IMIDs)—a group of chronic conditions including asthma, rheumatoid arthritis, and type 1 diabetes—that cause ...
Preliminary safety data from a French registry on combination therapy in immune-mediated inflammatory diseases (IMIDs) show a concerning rate of serious infections and illustrate the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results